Efficacy and tolerability of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy over 12 weeks in patients with type 2 diabetes
Author:
Publisher
Hindawi Limited
Subject
General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1742-1241.2006.01246.x/fullpdf
Reference15 articles.
1. Therapeutic strategies based on glucagon-like peptide 1;Deacon;Diabetes,2004
2. GLP-1 receptor agonists and DPP-4 inhibitors in the treatment of type 2 diabetes;Ahren;Horm Metab Res,2004
3. Inhibition of the activity of dipeptidyl-peptidase IV as a treatment for type 2 diabetes;Holst;Diabetes,1998
4. Glucagon-like peptide 1 and inhibitors of dipeptidyl peptidase IV in the treatment of type 2 diabetes mellitus;Holst;Curr Opin Pharmacol,2004
5. Gut peptides and type 2 diabetes mellitus treatment;Ahren;Curr Diab Rep,2003
Cited by 220 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Comparison of teneligliptin and other gliptin-based regimens in addressing insulin resistance and glycemic control in type 2 diabetic patients: a cross-sectional study;Expert Review of Endocrinology & Metabolism;2023-12-11
2. Pharmacokinetic comparison of sitagliptin and metformin HCl extended-release tablets versus JANUMET® XR in healthy volunteers under fasting and fed conditions;Frontiers in Pharmacology;2023-03-22
3. Choice of Glucose-Lowering Drugs as Initial Monotherapy for Type 2 Diabetes Patients with Contraindications or Intolerance to Metformin: A Systematic Review and Meta-Analysis;Journal of Clinical Medicine;2022-11-30
4. Comparisons of pleiotropic effects of SGLT2 inhibition and GLP-1 agonism on cardiac glucose intolerance in heart dysfunction;Molecular and Cellular Biochemistry;2022-05-22
5. A randomized clinical trial of the efficacy and safety of sitagliptin as initial oral therapy in youth with type 2 diabetes;Pediatric Diabetes;2021-12-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3